|
| |
Image Results
Loading...
Loading...
Cangene In Pages on BioPortfolio:
|
Biotechnology News bioterrorism terror anthrax smallpox Search
26 Oct 2009 ... Cangene makes sale to new, international customer ... 22 /CNW/ - Cangene Corporation today announces that it has finalized. ...
http://www.bioportfolio.co.uk/bioterrorism%20terror%20anthra...
|
BioPortfolio - Cangene Corporation - Profile
View the current Cangene Corporation Page on BioPortfolio.com ... Cangene corporation is a leading Canadian biopharmaceutical company that develops ...
http://www.bioportfolio.com/biocorporate/2393-Cangene%2BCorp...
|
Biotechnology News Hepatitis Search
Cangene Corporation (CC:CNJ) Acquires U.S. Commercialization Rights for HepaGam ... 19 /CNW/ - Cangene Corporation today announces that it has signed an ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...
|
BioPortfolio - Smallpox
Cangene is a world leader in the development , manufacture, and commercialization of specialty ... Cangene has built two decades of success with
the life. ...
http://www.bioportfolio.com/indepth/Smallpox.html...
|
BioPortfolio Limited The Future of the Biodefense Industry ...
Cangene 133. Contracts 135. ID Biomedical Corporation 135. Contracts 136. UK 136 . Acambis 136 ... Figure 5.10: Cangene financial results ($m), 2004-08 134 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_2082.html...
|
BioPortfolio - Biocorporate Search recombinant
Cangene corporation is a leading Canadian biopharmaceutical company that develops,manufactures and markets specialty plasma products (hyperimmunes) and
...
http://www.bioportfolio.com/biocorporate/search.php?q=recomb...
|
Bio-equities NASDAQ Biotechnology Stocks
Caliper - Cangene, Click Here. Centene - Cytrx, Click Here. Demegen - Dyax, Click Here. Epoch - Exelixis, Click Here. First Health - Genzyme, Click Here ...
http://www.bioportfolio.com/nasdaq/index.htm...
| Results from other life science and pharmaceutical sites:
Baxter News
28 Mar 2005 ... Cangene to Continue Manufacturing; Baxter Gains Exclusive U.S. Rights to Market Treatment for Bleeding Disorder ...
http://www.baxter.com/about_baxter/news_room/news_releases/2...
|
CANGENE CORP. - Google Finance
Get the latest on CANGENE CORP. including up to date news, high quality discussion groups and more on Google Finance.
http://www.google.com/finance?q=ETR:YGE...
|
Baxter News
DEERFIELD, Ill., TORONTO and WINNIPEG, Canada, April 11, 2005 – Baxter Healthcare Corporation and Cangene Corporation announced today that the U.S.
Food and ...
http://www.baxter.com/about_baxter/news_room/news_releases/2...
|
Cangene Corporation Acquires U.S. Commercialization Rights for ...
20 Oct 2009 ... TORONTO and WINNIPEG, Oct. 19 /CNW/ - Cangene Corporation today announces that it has signed an agreement with its majority shareholder, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=159674...
|
Cangene to host fiscal 2009 conference call on Thursday October 22 ...
20 Oct 2009 ... Listed TSX, Symbol: CNJ TORONTO and WINNIPEG, Oct. 20 /CNW/ - Cangene Corporation today announces that it intends to host a.
http://biz.yahoo.com/cnw/091020/cangene_confrnce_call.html?....
|
BioSpace - Cangene Corporation News, Search Jobs, Events
20 Oct 2009 ... Cangene Corporation 104 Chancellor Matheson Road Winnipeg Manitoba R3T 5Y3 Canada Phone: 204-275-4200 Fax: ...
http://www.biospace.com/company_profile.aspx?CompanyId=4200...
|
Cangene makes sale to new, international customer - Yahoo! Finance
22 Sep 2009 ... Readers are referred to the cautionary notes regarding Forward-looking and.
http://biz.yahoo.com/cnw/090922/cangene_finalize_deal.html?....
|
Cangene Corporation Acquires Twinstrand Therapeutics - News ...
8 Jul 2009 ... TORONTO and WINNIPEG, July 7 /CNW/ - Cangene Corporation today announces that it has acquired all issued and outstanding shares of privately ...
http://www.biospace.com/news_story.aspx?NewsEntityId=149213...
|
News: Cangene Buys Exclusive Option for Acute Radiation Syndrome ...
8 May 2009 ... Cangene will exercise its right if it obtains a government contract for development. Bid to BARDA regarding MAXY-G34 protein therapeutic.
http://www.genengnews.com/news/bnitem.aspx?name=54075109...
|
{2} And {3} Announce U.S. {4} Approval Of Liquid Formulation Of ...
Last month, Baxter assumed from Cangene exclusive rights to market and distribute WinRho SDF in the U.S., a lyophilized version of which has been
available ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1963822...
|
|
